Daniel A Leffler

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Health Insurance

Ejection Fraction

Top Venues

Alimentary pharmacology & therapeutics

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Javier A Villafuerte Gálvez, Daniel A Leffler
Editorial: Peering through the fog-New tools to assess neurocognitive symptoms in coeliac disease. Alimentary pharmacology & therapeutics 59 (12) (2024)
Javier A Villafuerte Gálvez, Daniel A Leffler
Editorial: Peering through the fog-New tools to assess neurocognitive symptoms in coeliac disease. Alimentary pharmacology & therapeutics 59 (12) (2024)
Javier A Villafuerte Gálvez, Daniel A Leffler
Editorial: Peering through the fog-New tools to assess neurocognitive symptoms in coeliac disease. Alimentary pharmacology & therapeutics (2024)
Annalisa Schiepatti, Anupam Rej, Stiliano Maimaris, Simon S Cross, Petra Porta, Imran Aziz, Tim Key, John Goodwin, Amelie Therrien, Shakira Yoosuf, Daniel A Leffler, Jocelyn A Silvester, Catherine Klersy, Federico Biagi, David S Sanders
Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study. Alimentary pharmacology & therapeutics 54 (10) (2021)
Amelie Therrien, Daniel A Leffler
Editorial: coeliac disease-it's a family affair. Alimentary pharmacology & therapeutics 54 (7) (2021)
Elizabeth S Mearns, Aliki Taylor, Talia Boulanger, Kelly Jean Thomas Craig, Michele Gerber, Daniel A Leffler, Jennifer Drahos, David S Sanders, Benjamin Lebwohl
Systematic Literature Review of the Economic Burden of Celiac Disease. PharmacoEconomics 37 (1) (2020)